Location: Home > News
2026-09-15
【News Interpretation】Focus on NMPA Announcement No.86: Consistency Evaluation of Eye Drops Launched, Changzhou Xianglong Rolls Out Full-Chain Quality Control Reference Material Solutions Simultaneously！
Under the strict regulatory system for the consistency evaluation of eye drops, selecting a compliant reference standard manufacturer is a top priority!...
15
2026-09
2026-09-07
[News Analysis] From a 380 Million Penalty Fine to Febuxostat Impurity K: Compliant Reference Standards as the Invisible Defense for Pharmaceuticals and Food Safety!
Compliance reference standards serve as the invisible defense line for drug and food safety!...
07
2026-09
2026-08-24
【Good News】Accurate measurement, well done! Xianglong Pharmaceutical has been awarded CNAS 17034 accreditation, and with CNAS 17025 accreditation and GBW (E) national standards, it has built a "dual system+national standard" quality moat!
Unite with one heart and create brilliance together!...
24
2026-08
2026-08-14
[Xianglong Classroom] Analysis of Impurity Spectrum in Ondansetron: The Chemical Game Between the Carbazole Core and the Imidazole Side Chain!
Welcome to purchase our products....
14
2026-08
2026-08-10
【New Product Recommendation】Heavyweight Launch of Tribenzoglycoside-Related Impurity Reference Standards, One-Stop Solution for R&D Quality Control Challenges!
We have meticulously selected and launched a series of tribenzoyl glucoside impurity reference standards to enhance pharmaceutical quality!...
10
2026-08
2026-07-22
【New Product Recommendation】Seize the Opportunity in RAS Target Drug Development: High-Purity Impurity Reference Standards to Safeguard the Quality Research of Your Innovative Drugs!
The RAS target is a highly significant oncogenic gene locus in the field of cancer treatment. Once the protein it controls mutates, it can cause uncontrolled cell growth, and approximately 30% of human cancers are associated with it....
22
2026-07
2026-07-10
【Quality Product Recommendation】Stuck on the Ishalumab project timeline? Choose the right impurity reference standard to save three months of detours.
Ixazomib (trade name: Ninlaro) is the world's first orally administered, highly selective proteasome inhibitor, classified as a targeted anti-tumor prescription drug. Approved for marketing in China in 2018, it has been included in the national medical insurance list (Category B)...
10
2026-07
2026-06-25
Igniting the Stage! Changzhou Xianglong Pharmaceutical Concludes Successfully at CPHI China 2026!
Keep moving forward, thank you to your colleagues! See you at our next exhibition!...
25
2026-06
2026-05-22
【Product Recommendation】Mupirocin: The "Skin Guardian" Among Topical Antibiotics!
Mupirocin, also known as pseudomonic acid, is an antibiotic medication. On January 18, 2008, it was approved by the National Medical Products Administration to transition from prescription drug to over-the-counter drug....
22
2026-05
2026-04-14
【In Stock】"New Weapon" for Reducing Proteinuria: How Arecorin Works as a "Brake" for Chronic Kidney Disease?
New Hope for Delaying Kidney Failure: A Comprehensive Guide to Atrasentan....
14
2026-04